24.7 C
Lagos
Friday, December 4, 2020
- Advertisement -

In Talks with Big Pharma, Osinbajo Requests Priority for Nigeria Once Coronavirus Vaccine is Developed

Opinion

CNN and the Ethics of Journalism – By Lai Mohammed

Our attention has been drawn to an ‘investigation’ by CNN, entitled ‘How a Bloody Night of Bullets Quashed a Young Protest Movement’...

Drug Use: The Forgotten Epidemic – By M. Buba Marwa and Oliver Stolpe

In 2018, the National Bureau of Statistics (NBS) in cooperation with the United Nations Office on Drugs and Crime and the European...

Understanding the American Three-Stage Presidential Election – By Solomon Ukhuegbe

The United States presidential election of November 3, 2020 eclipsed the election at the same time for all seats of the U.S....

Bukola Saraki’s Homecoming – By Alabi Olayemi

Former Senate President Bukola Saraki breezed into Ilorin, the capital city of Kwara State, on Saturday November 14. The day coincided with...

Nigeria’s Vice President Yemi Osinbajo said during a virtual meeting with senior government officials and representatives of Big Pharma that the Buhari administration intends to examine every possible option in the development and distribution of a vaccine against the COVID-19 coronavirus, and that the health and safety of Nigerian citizens remains the government’s priority.

Mr Osinbajo said this during a meeting with representatives of the BNT162 COVID-19 vaccine candidate on the progress of the development of the vaccine. The meeting had in attendance Health Minister, Osagie Ehanire, the Executive Director of the National Primary Health Care Development Agency, Faisal Shuaib and representatives of Pfizer and Biotech, the international pharmaceutical firms promoting the BNT162 vaccine candidate.

Mr Osinbajo said the interaction between the Nigerian government and the promoters of the vaccine candidate “is an important conversation and it is important for us that we are prioritized-as the largest country in Africa-in the distribution of the best COVID-19 vaccine when it is eventually ready.

“Our priority is the health of the Nigerian citizens. We continue to engage and intend to look at every possible option -from all manufacturers- of a good vaccine. We want to do the very best for our people in this regard.”

The Vice President asked several questions about the COVID-19 vaccine candidate during the meeting, including how quickly can Nigeria get the vaccine once it becomes available.

Mr Olayinka Subair, Pfizer’s Country Manager and Representative in Africa, who spoke on behalf of the promoters, said that “Nigeria will be a priority.” Although the vaccine is not currently being tested in Nigeria, he said the trails are ongoing in parts of the African continent and would be entering the third phase after two successful phases.

- Advertisement -
- Advertisement -

Business Profiles

Maria Kiwanuka

Maria Kiwanuka is the Chairperson of the Board of Directors UBA Uganda. Maria Kiwanuka is an Economist by profession and a former...

Chioma Mang

Chioma is a seasoned banker with almost 3 decades of combined experience at top management and executive levels in banking spanning Treasury...

Ebele Ogbue

Ebele Ogbue is the General Manager, UBA Energy Bank at United Bank for Africa (UBA) Plc. His responsibilities are to acquire, deepen...

Kenneth Orji

Mr. Orji was educated at the University of Ibadan, Nigeria where he was a J. F. Kennedy Scholar, having emerged national first...

Kubi Momoh

Kubi Momoh is the Chief Risk Officer at NOVA Merchant Bank Limited. She was previously the Chief Risk Officer, UBA Africa with...